The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Non-opioid Pain Patches Market Research Report 2025
Synopsis
The global Non-opioid Pain Patches market was valued at US$ 631.4 million in 2023 and is anticipated to reach US$ 779.5 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Non-opioid Pain Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-opioid Pain Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patches.
Report Scope
The Non-opioid Pain Patches market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Pain Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Pain Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Pain Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Non-opioid Pain Patches market was valued at US$ 631.4 million in 2023 and is anticipated to reach US$ 779.5 million by 2030, witnessing a CAGR of 2.6% during the forecast period 2024-2030.
North American market for Non-opioid Pain Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Non-opioid Pain Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Non-opioid Pain Patches include Pfizer, GlaxoSmithKline, Johnson & Johnson, Novartis AG, Mylan N.V., Teva Pharmaceutical Industries, Hisamitsu Pharmaceutical, TEH SENG Pharmaceutical and Teikoku Seiyaku, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Non-opioid Pain Patches, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-opioid Pain Patches.
Report Scope
The Non-opioid Pain Patches market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Non-opioid Pain Patches market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Non-opioid Pain Patches manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
GlaxoSmithKline
Johnson & Johnson
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Hisamitsu Pharmaceutical
TEH SENG Pharmaceutical
Teikoku Seiyaku
IBSA Institut Biochimque SA
Acorda Therapeutics
Allergan PLC
Endo International
Segment by Type
Lidocaine Patch
Diclofenac Patch
Methyl Salicylate Patch
Capsaicin Patch
Ketoprofen Patch
Others
Segment by Application
Hospital Pharmacies
Independent Pharmacies & Drug Stores
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Non-opioid Pain Patches manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Non-opioid Pain Patches in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Non-opioid Pain Patches Market Overview
1.1 Product Overview and Scope of Non-opioid Pain Patches
1.2 Non-opioid Pain Patches Segment by Type
1.2.1 Global Non-opioid Pain Patches Market Value Comparison by Type (2024-2030)
1.2.2 Lidocaine Patch
1.2.3 Diclofenac Patch
1.2.4 Methyl Salicylate Patch
1.2.5 Capsaicin Patch
1.2.6 Ketoprofen Patch
1.2.7 Others
1.3 Non-opioid Pain Patches Segment by Application
1.3.1 Global Non-opioid Pain Patches Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Independent Pharmacies & Drug Stores
1.3.4 Online Pharmacies
1.4 Global Non-opioid Pain Patches Market Size Estimates and Forecasts
1.4.1 Global Non-opioid Pain Patches Revenue 2019-2030
1.4.2 Global Non-opioid Pain Patches Sales 2019-2030
1.4.3 Global Non-opioid Pain Patches Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Non-opioid Pain Patches Market Competition by Manufacturers
2.1 Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2019-2024)
2.2 Global Non-opioid Pain Patches Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Non-opioid Pain Patches Average Price by Manufacturers (2019-2024)
2.4 Global Non-opioid Pain Patches Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Non-opioid Pain Patches, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Non-opioid Pain Patches, Product Type & Application
2.7 Non-opioid Pain Patches Market Competitive Situation and Trends
2.7.1 Non-opioid Pain Patches Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Non-opioid Pain Patches Players Market Share by Revenue
2.7.3 Global Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Non-opioid Pain Patches Retrospective Market Scenario by Region
3.1 Global Non-opioid Pain Patches Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Non-opioid Pain Patches Global Non-opioid Pain Patches Sales by Region: 2019-2030
3.2.1 Global Non-opioid Pain Patches Sales by Region: 2019-2024
3.2.2 Global Non-opioid Pain Patches Sales by Region: 2025-2030
3.3 Global Non-opioid Pain Patches Global Non-opioid Pain Patches Revenue by Region: 2019-2030
3.3.1 Global Non-opioid Pain Patches Revenue by Region: 2019-2024
3.3.2 Global Non-opioid Pain Patches Revenue by Region: 2025-2030
3.4 North America Non-opioid Pain Patches Market Facts & Figures by Country
3.4.1 North America Non-opioid Pain Patches Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Non-opioid Pain Patches Sales by Country (2019-2030)
3.4.3 North America Non-opioid Pain Patches Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Non-opioid Pain Patches Market Facts & Figures by Country
3.5.1 Europe Non-opioid Pain Patches Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Non-opioid Pain Patches Sales by Country (2019-2030)
3.5.3 Europe Non-opioid Pain Patches Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Non-opioid Pain Patches Market Facts & Figures by Country
3.6.1 Asia Pacific Non-opioid Pain Patches Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Non-opioid Pain Patches Sales by Country (2019-2030)
3.6.3 Asia Pacific Non-opioid Pain Patches Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Non-opioid Pain Patches Market Facts & Figures by Country
3.7.1 Latin America Non-opioid Pain Patches Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Non-opioid Pain Patches Sales by Country (2019-2030)
3.7.3 Latin America Non-opioid Pain Patches Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Non-opioid Pain Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Non-opioid Pain Patches Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Non-opioid Pain Patches Sales by Country (2019-2030)
3.8.3 Middle East and Africa Non-opioid Pain Patches Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Non-opioid Pain Patches Sales by Type (2019-2030)
4.1.1 Global Non-opioid Pain Patches Sales by Type (2019-2024)
4.1.2 Global Non-opioid Pain Patches Sales by Type (2025-2030)
4.1.3 Global Non-opioid Pain Patches Sales Market Share by Type (2019-2030)
4.2 Global Non-opioid Pain Patches Revenue by Type (2019-2030)
4.2.1 Global Non-opioid Pain Patches Revenue by Type (2019-2024)
4.2.2 Global Non-opioid Pain Patches Revenue by Type (2025-2030)
4.2.3 Global Non-opioid Pain Patches Revenue Market Share by Type (2019-2030)
4.3 Global Non-opioid Pain Patches Price by Type (2019-2030)
5 Segment by Application
5.1 Global Non-opioid Pain Patches Sales by Application (2019-2030)
5.1.1 Global Non-opioid Pain Patches Sales by Application (2019-2024)
5.1.2 Global Non-opioid Pain Patches Sales by Application (2025-2030)
5.1.3 Global Non-opioid Pain Patches Sales Market Share by Application (2019-2030)
5.2 Global Non-opioid Pain Patches Revenue by Application (2019-2030)
5.2.1 Global Non-opioid Pain Patches Revenue by Application (2019-2024)
5.2.2 Global Non-opioid Pain Patches Revenue by Application (2025-2030)
5.2.3 Global Non-opioid Pain Patches Revenue Market Share by Application (2019-2030)
5.3 Global Non-opioid Pain Patches Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Non-opioid Pain Patches Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Non-opioid Pain Patches Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Corporation Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Johnson & Johnson Non-opioid Pain Patches Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Novartis AG
6.4.1 Novartis AG Corporation Information
6.4.2 Novartis AG Description and Business Overview
6.4.3 Novartis AG Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novartis AG Non-opioid Pain Patches Product Portfolio
6.4.5 Novartis AG Recent Developments/Updates
6.5 Mylan N.V.
6.5.1 Mylan N.V. Corporation Information
6.5.2 Mylan N.V. Description and Business Overview
6.5.3 Mylan N.V. Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan N.V. Non-opioid Pain Patches Product Portfolio
6.5.5 Mylan N.V. Recent Developments/Updates
6.6 Teva Pharmaceutical Industries
6.6.1 Teva Pharmaceutical Industries Corporation Information
6.6.2 Teva Pharmaceutical Industries Description and Business Overview
6.6.3 Teva Pharmaceutical Industries Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Teva Pharmaceutical Industries Non-opioid Pain Patches Product Portfolio
6.6.5 Teva Pharmaceutical Industries Recent Developments/Updates
6.7 Hisamitsu Pharmaceutical
6.6.1 Hisamitsu Pharmaceutical Corporation Information
6.6.2 Hisamitsu Pharmaceutical Description and Business Overview
6.6.3 Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hisamitsu Pharmaceutical Non-opioid Pain Patches Product Portfolio
6.7.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.8 TEH SENG Pharmaceutical
6.8.1 TEH SENG Pharmaceutical Corporation Information
6.8.2 TEH SENG Pharmaceutical Description and Business Overview
6.8.3 TEH SENG Pharmaceutical Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.8.4 TEH SENG Pharmaceutical Non-opioid Pain Patches Product Portfolio
6.8.5 TEH SENG Pharmaceutical Recent Developments/Updates
6.9 Teikoku Seiyaku
6.9.1 Teikoku Seiyaku Corporation Information
6.9.2 Teikoku Seiyaku Description and Business Overview
6.9.3 Teikoku Seiyaku Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Teikoku Seiyaku Non-opioid Pain Patches Product Portfolio
6.9.5 Teikoku Seiyaku Recent Developments/Updates
6.10 IBSA Institut Biochimque SA
6.10.1 IBSA Institut Biochimque SA Corporation Information
6.10.2 IBSA Institut Biochimque SA Description and Business Overview
6.10.3 IBSA Institut Biochimque SA Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.10.4 IBSA Institut Biochimque SA Non-opioid Pain Patches Product Portfolio
6.10.5 IBSA Institut Biochimque SA Recent Developments/Updates
6.11 Acorda Therapeutics
6.11.1 Acorda Therapeutics Corporation Information
6.11.2 Acorda Therapeutics Non-opioid Pain Patches Description and Business Overview
6.11.3 Acorda Therapeutics Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Acorda Therapeutics Non-opioid Pain Patches Product Portfolio
6.11.5 Acorda Therapeutics Recent Developments/Updates
6.12 Allergan PLC
6.12.1 Allergan PLC Corporation Information
6.12.2 Allergan PLC Non-opioid Pain Patches Description and Business Overview
6.12.3 Allergan PLC Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Allergan PLC Non-opioid Pain Patches Product Portfolio
6.12.5 Allergan PLC Recent Developments/Updates
6.13 Endo International
6.13.1 Endo International Corporation Information
6.13.2 Endo International Non-opioid Pain Patches Description and Business Overview
6.13.3 Endo International Non-opioid Pain Patches Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Endo International Non-opioid Pain Patches Product Portfolio
6.13.5 Endo International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Non-opioid Pain Patches Industry Chain Analysis
7.2 Non-opioid Pain Patches Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Non-opioid Pain Patches Production Mode & Process
7.4 Non-opioid Pain Patches Sales and Marketing
7.4.1 Non-opioid Pain Patches Sales Channels
7.4.2 Non-opioid Pain Patches Distributors
7.5 Non-opioid Pain Patches Customers
8 Non-opioid Pain Patches Market Dynamics
8.1 Non-opioid Pain Patches Industry Trends
8.2 Non-opioid Pain Patches Market Drivers
8.3 Non-opioid Pain Patches Market Challenges
8.4 Non-opioid Pain Patches Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Non-opioid Pain Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Non-opioid Pain Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Non-opioid Pain Patches Market Competitive Situation by Manufacturers in 2023
Table 4. Global Non-opioid Pain Patches Sales (K Pcs) of Key Manufacturers (2019-2024)
Table 5. Global Non-opioid Pain Patches Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Non-opioid Pain Patches Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Non-opioid Pain Patches Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Non-opioid Pain Patches Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Non-opioid Pain Patches, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Non-opioid Pain Patches, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Non-opioid Pain Patches, Product Type & Application
Table 12. Global Key Manufacturers of Non-opioid Pain Patches, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Non-opioid Pain Patches by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-opioid Pain Patches as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Non-opioid Pain Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Non-opioid Pain Patches Sales by Region (2019-2024) & (K Pcs)
Table 18. Global Non-opioid Pain Patches Sales Market Share by Region (2019-2024)
Table 19. Global Non-opioid Pain Patches Sales by Region (2025-2030) & (K Pcs)
Table 20. Global Non-opioid Pain Patches Sales Market Share by Region (2025-2030)
Table 21. Global Non-opioid Pain Patches Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Non-opioid Pain Patches Revenue Market Share by Region (2019-2024)
Table 23. Global Non-opioid Pain Patches Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Non-opioid Pain Patches Revenue Market Share by Region (2025-2030)
Table 25. North America Non-opioid Pain Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Non-opioid Pain Patches Sales by Country (2019-2024) & (K Pcs)
Table 27. North America Non-opioid Pain Patches Sales by Country (2025-2030) & (K Pcs)
Table 28. North America Non-opioid Pain Patches Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Non-opioid Pain Patches Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Non-opioid Pain Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Non-opioid Pain Patches Sales by Country (2019-2024) & (K Pcs)
Table 32. Europe Non-opioid Pain Patches Sales by Country (2025-2030) & (K Pcs)
Table 33. Europe Non-opioid Pain Patches Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Non-opioid Pain Patches Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Non-opioid Pain Patches Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Non-opioid Pain Patches Sales by Region (2019-2024) & (K Pcs)
Table 37. Asia Pacific Non-opioid Pain Patches Sales by Region (2025-2030) & (K Pcs)
Table 38. Asia Pacific Non-opioid Pain Patches Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Non-opioid Pain Patches Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Non-opioid Pain Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Non-opioid Pain Patches Sales by Country (2019-2024) & (K Pcs)
Table 42. Latin America Non-opioid Pain Patches Sales by Country (2025-2030) & (K Pcs)
Table 43. Latin America Non-opioid Pain Patches Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Non-opioid Pain Patches Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Non-opioid Pain Patches Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Non-opioid Pain Patches Sales by Country (2019-2024) & (K Pcs)
Table 47. Middle East & Africa Non-opioid Pain Patches Sales by Country (2025-2030) & (K Pcs)
Table 48. Middle East & Africa Non-opioid Pain Patches Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Non-opioid Pain Patches Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Non-opioid Pain Patches Sales (K Pcs) by Type (2019-2024)
Table 51. Global Non-opioid Pain Patches Sales (K Pcs) by Type (2025-2030)
Table 52. Global Non-opioid Pain Patches Sales Market Share by Type (2019-2024)
Table 53. Global Non-opioid Pain Patches Sales Market Share by Type (2025-2030)
Table 54. Global Non-opioid Pain Patches Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Non-opioid Pain Patches Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Non-opioid Pain Patches Revenue Market Share by Type (2019-2024)
Table 57. Global Non-opioid Pain Patches Revenue Market Share by Type (2025-2030)
Table 58. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2019-2024)
Table 59. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2025-2030)
Table 60. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2019-2024)
Table 61. Global Non-opioid Pain Patches Sales (K Pcs) by Application (2025-2030)
Table 62. Global Non-opioid Pain Patches Sales Market Share by Application (2019-2024)
Table 63. Global Non-opioid Pain Patches Sales Market Share by Application (2025-2030)
Table 64. Global Non-opioid Pain Patches Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Non-opioid Pain Patches Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Non-opioid Pain Patches Revenue Market Share by Application (2019-2024)
Table 67. Global Non-opioid Pain Patches Revenue Market Share by Application (2025-2030)
Table 68. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2019-2024)
Table 69. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 73. Pfizer Non-opioid Pain Patches Product
Table 74. Pfizer Recent Developments/Updates
Table 75. GlaxoSmithKline Corporation Information
Table 76. GlaxoSmithKline Description and Business Overview
Table 77. GlaxoSmithKline Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 78. GlaxoSmithKline Non-opioid Pain Patches Product
Table 79. GlaxoSmithKline Recent Developments/Updates
Table 80. Johnson & Johnson Corporation Information
Table 81. Johnson & Johnson Description and Business Overview
Table 82. Johnson & Johnson Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 83. Johnson & Johnson Non-opioid Pain Patches Product
Table 84. Johnson & Johnson Recent Developments/Updates
Table 85. Novartis AG Corporation Information
Table 86. Novartis AG Description and Business Overview
Table 87. Novartis AG Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 88. Novartis AG Non-opioid Pain Patches Product
Table 89. Novartis AG Recent Developments/Updates
Table 90. Mylan N.V. Corporation Information
Table 91. Mylan N.V. Description and Business Overview
Table 92. Mylan N.V. Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 93. Mylan N.V. Non-opioid Pain Patches Product
Table 94. Mylan N.V. Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Corporation Information
Table 96. Teva Pharmaceutical Industries Description and Business Overview
Table 97. Teva Pharmaceutical Industries Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries Non-opioid Pain Patches Product
Table 99. Teva Pharmaceutical Industries Recent Developments/Updates
Table 100. Hisamitsu Pharmaceutical Corporation Information
Table 101. Hisamitsu Pharmaceutical Description and Business Overview
Table 102. Hisamitsu Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 103. Hisamitsu Pharmaceutical Non-opioid Pain Patches Product
Table 104. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 105. TEH SENG Pharmaceutical Corporation Information
Table 106. TEH SENG Pharmaceutical Description and Business Overview
Table 107. TEH SENG Pharmaceutical Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 108. TEH SENG Pharmaceutical Non-opioid Pain Patches Product
Table 109. TEH SENG Pharmaceutical Recent Developments/Updates
Table 110. Teikoku Seiyaku Corporation Information
Table 111. Teikoku Seiyaku Description and Business Overview
Table 112. Teikoku Seiyaku Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 113. Teikoku Seiyaku Non-opioid Pain Patches Product
Table 114. Teikoku Seiyaku Recent Developments/Updates
Table 115. IBSA Institut Biochimque SA Corporation Information
Table 116. IBSA Institut Biochimque SA Description and Business Overview
Table 117. IBSA Institut Biochimque SA Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 118. IBSA Institut Biochimque SA Non-opioid Pain Patches Product
Table 119. IBSA Institut Biochimque SA Recent Developments/Updates
Table 120. Acorda Therapeutics Corporation Information
Table 121. Acorda Therapeutics Description and Business Overview
Table 122. Acorda Therapeutics Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Acorda Therapeutics Non-opioid Pain Patches Product
Table 124. Acorda Therapeutics Recent Developments/Updates
Table 125. Allergan PLC Corporation Information
Table 126. Allergan PLC Description and Business Overview
Table 127. Allergan PLC Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 128. Allergan PLC Non-opioid Pain Patches Product
Table 129. Allergan PLC Recent Developments/Updates
Table 130. Endo International Corporation Information
Table 131. Endo International Description and Business Overview
Table 132. Endo International Non-opioid Pain Patches Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
Table 133. Endo International Non-opioid Pain Patches Product
Table 134. Endo International Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Non-opioid Pain Patches Distributors List
Table 138. Non-opioid Pain Patches Customers List
Table 139. Non-opioid Pain Patches Market Trends
Table 140. Non-opioid Pain Patches Market Drivers
Table 141. Non-opioid Pain Patches Market Challenges
Table 142. Non-opioid Pain Patches Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Non-opioid Pain Patches
Figure 2. Global Non-opioid Pain Patches Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Non-opioid Pain Patches Market Share by Type in 2023 & 2030
Figure 4. Lidocaine Patch Product Picture
Figure 5. Diclofenac Patch Product Picture
Figure 6. Methyl Salicylate Patch Product Picture
Figure 7. Capsaicin Patch Product Picture
Figure 8. Ketoprofen Patch Product Picture
Figure 9. Others Product Picture
Figure 10. Global Non-opioid Pain Patches Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global Non-opioid Pain Patches Market Share by Application in 2023 & 2030
Figure 12. Hospital Pharmacies
Figure 13. Independent Pharmacies & Drug Stores
Figure 14. Online Pharmacies
Figure 15. Global Non-opioid Pain Patches Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Non-opioid Pain Patches Market Size (2019-2030) & (US$ Million)
Figure 17. Global Non-opioid Pain Patches Sales (2019-2030) & (K Pcs)
Figure 18. Global Non-opioid Pain Patches Average Price (USD/Pcs) & (2019-2030)
Figure 19. Non-opioid Pain Patches Report Years Considered
Figure 20. Non-opioid Pain Patches Sales Share by Manufacturers in 2023
Figure 21. Global Non-opioid Pain Patches Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest Non-opioid Pain Patches Players: Market Share by Revenue in 2023
Figure 23. Non-opioid Pain Patches Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global Non-opioid Pain Patches Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America Non-opioid Pain Patches Sales Market Share by Country (2019-2030)
Figure 26. North America Non-opioid Pain Patches Revenue Market Share by Country (2019-2030)
Figure 27. U.S. Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe Non-opioid Pain Patches Sales Market Share by Country (2019-2030)
Figure 30. Europe Non-opioid Pain Patches Revenue Market Share by Country (2019-2030)
Figure 31. Germany Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Non-opioid Pain Patches Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific Non-opioid Pain Patches Revenue Market Share by Region (2019-2030)
Figure 38. China Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Taiwan Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Indonesia Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Thailand Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Malaysia Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Philippines Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Latin America Non-opioid Pain Patches Sales Market Share by Country (2019-2030)
Figure 49. Latin America Non-opioid Pain Patches Revenue Market Share by Country (2019-2030)
Figure 50. Mexico Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Brazil Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Argentina Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Middle East & Africa Non-opioid Pain Patches Sales Market Share by Country (2019-2030)
Figure 54. Middle East & Africa Non-opioid Pain Patches Revenue Market Share by Country (2019-2030)
Figure 55. Turkey Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Saudi Arabia Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 57. U.A.E Non-opioid Pain Patches Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 58. Global Sales Market Share of Non-opioid Pain Patches by Type (2019-2030)
Figure 59. Global Revenue Market Share of Non-opioid Pain Patches by Type (2019-2030)
Figure 60. Global Non-opioid Pain Patches Price (USD/Pcs) by Type (2019-2030)
Figure 61. Global Sales Market Share of Non-opioid Pain Patches by Application (2019-2030)
Figure 62. Global Revenue Market Share of Non-opioid Pain Patches by Application (2019-2030)
Figure 63. Global Non-opioid Pain Patches Price (USD/Pcs) by Application (2019-2030)
Figure 64. Non-opioid Pain Patches Value Chain
Figure 65. Non-opioid Pain Patches Production Process
Figure 66. Channels of Distribution (Direct Vs Distribution)
Figure 67. Distributors Profiles
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
